Top Markets
Coin of the day
New Horizon Health Limited New Horizon Health Limited

New Horizon Health Limited

6606
Rank in Stocks #10979
New Horizon Health Limited functions as an investment holding company,... New Horizon Health Limited functions as an investment holding company, primarily focusing on the research and development of screening products for various cancers, including colorectal and cervical, within the People's Republic of China. The firm also engages in the advancement of medical diagnostic technology. Its operations extend to providing a range of services such as technical support, technology transfers, consulting, medical assistance, and financing. Furthermore, the company manufactures and distributes medical and laboratory equipment, notably specialized fecal occult blood test kits, and is involved in technology import and export activities. Established in 2013, its headquarters are located in Hangzhou, China.
Share Price
$1.82
Last synced: 2024-11-03
Market Cap
$759.89M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CN
Trade New Horizon Health Limited (6606)

Category

P/E ratio for New Horizon Health Limited (6606)
P/E ratio as of 2026 TTM: 0
According to New Horizon Health Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for New Horizon Health Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
35.77 -
US
34.86 -
US
21.39 -
IE
20.90 -
US
- -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.